Foxo1 regulates marginal zone B-cell development

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1890-1896

  Chen, Jing ^a   Limon, Jose J ^a   Blanc, Caroline ^a   Peng, Stanford L ^b,c   Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

B cells; B cell development; Signal transduction; Transcription factors

Indexed keywords

CD19 ANTIGEN; TRANSCRIPTION FACTOR FKHR; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CELL SEPARATION; EMBRYOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PRE B LYMPHOCYTE;

ANIMALS; ANTIGENS, CD19; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOGLOBULIN CLASS SWITCHING; MICE; MICE, KNOCKOUT; PRECURSOR CELLS, B-LYMPHOID; SPLEEN;

EID: 77954125132     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939817     Document Type: Article

References (35)

1. Fruman, D. A. and Bismuth, G., Fine tuning the immune response with PI3K. Immunol. Rev. 2009. 228: 253-272.
2. Carter, R. H.,Wang, Y. and Brooks, S., Role of CD19 signal transduction in B cell biology. Immunol. Res. 2002. 26: 45-54.
3. Del Nagro, C. J., Otero, D. C., Anzelon, A. N., Omori, S. A., Kolla, R. V. and Rickert, R. C., CD19 function in central and peripheral B-cell development. Immunol. Res. 2005. 31: 119-131.
4. Depoil, D., Fleire, S., Treanor, B. L., Weber, M., Harwood, N. E., Marchbank, K. L., Tybulewicz, V. L. and Batista, F. D., CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 2008. 9: 63-72.
5. Wang, Y., Brooks, S. R., Li, X., Anzelon, A. N., Rickert, R. C. and Carter, R. H., The physiologic role of CD19 cytoplasmic tyrosines. Immunity 2002. 17: 501-514.
6. Calamito, M., Juntilla, M. M., Thomas, M., Northrup, D. L., Rathmell, J., Birnbaum, M. J., Koretzky, G. and Allman, D., Akt1 and Akt2 promote peripheral B cell maturation and survival. Blood 2010. 115: 4043-4050.
7. You, Y., Zhao, H., Wang, Y. and Carter, R. H., Cutting edge: primary and secondary effects of CD19 deficiency on cells of the marginal zone. J. Immunol. 2009. 182: 7343-7347.
8. Peng, S. L., Foxo in the immune system. Oncogene 2008. 27: 2337-2344.
9. van der Vos, K. E. and Coffer, P. J., FOXO-binding partners: it takes two to tango. Oncogene 2008. 27: 2289-2299.
10. Dengler, H. S., Baracho, G. V., Omori, S. A., Bruckner, S., Arden, K. C., Castrillon, D. H., DePinho, R. A. and Rickert, R. C., Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat. Immunol. 2008. 9: 1388-1398.
11. Gubbels Bupp, M. R., Edwards, B., Guo, C., Wei, D., Chen, G., Wong, B., Masteller, E. and Peng, S. L., T cells require Foxo1 to populate the peripheral lymphoid organs. Eur. J. Immunol. 2009. 39: 2991-2999.
12. Rickert, R. C., Roes, J. and Rajewsky, K., B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997. 25: 1317-1318.
13. Allman, D. and Pillai, S., Peripheral B cell subsets. Curr. Opin. Immunol. 2008. 20: 149-157.
14. Donahue, A. C. and Fruman, D. A., Distinct signaling mechanisms activate the target of rapamycin in response to different B-cell stimuli. Eur. J. Immunol. 2007. 37: 2923-2936.
15. Oliver, A. M., Martin, F., Gartland, G. L., Carter, R. H. and Kearney, J. F., Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997. 27: 2366-2374.
16. Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A. K. and Flavell, R. A., Transforming growth factor-beta regulation of immune responses. Annu. Rev. Immunol. 2006. 24: 99-146.
17. Gomis, R. R., Alarcon, C., He, W., Wang, Q., Seoane, J., Lash, A. and Massague, J., A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 2006. 103: 12747-12752.
18. Seoane, J., Le, H. V., Shen, L., Anderson, S. A. and Massague, J., Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 2004. 117: 211-223.
19. Klein, J., Ju, W., Heyer, J., Wittek, B., Haneke, T., Knaus, P., Kucherlapati, R. et al., B cell-specific deficiency for Smad2 in vivo leads to defects in TGF-beta-directed IgA switching and changes in B cell fate. J. Immunol. 2006. 176: 2389-2396.
20. Fabre, S., Carrette, F., Chen, J., Lang, V., Semichon, M., Denoyelle, C., Lazar, V. et al., FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J. Immunol. 2008. 181: 2980-2989.
21. Kerdiles, Y. M., Beisner, D. R., Tinoco, R., Dejean, A. S., Castrillon, D. H., DePinho, R. A. and Hedrick, S. M., Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 2009. 10: 176-184.
22. Ouyang, W., Beckett, O., Flavell, R. A. and Li, M. O., An essential role of the forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009. 30: 358-371.
23. Carlson, C. M., Endrizzi, B. T.,Wu, J., Ding, X.,Weinreich, M. A.,Walsh, E. R.,Wani, M. A. et al., Kruppel-like factor 2 regulates thymocyte and T-cell migration. Nature 2006. 442: 299-302.
24. Sebzda, E., Zou, Z., Lee, J. S., Wang, T. and Kahn, M. L., Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol. 2008. 9: 292-300.
25. Sinclair, L. V., Finlay, D., Feijoo, C., Cornish, G. H., Gray, A., Ager, A., Okkenhaug, K. et al., Phosphatidylinositol-3-OH kinase and nutrientsensing mTOR pathways control T lymphocyte trafficking. Nat. Immunol. 2008. 9: 513-521.
26. Chen, J., Yusuf, I., Andersen, H. M. and Fruman, D. A., FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes. J. Immunol. 2006. 176: 2711-2721. (Pubitemid 43306929)
27. Yusuf, I., Kharas, M. G., Chen, J., Peralta, R. Q., Maruniak, A., Sareen, P., Yang, V. W. et al., KLF4 is a FOXO target gene that suppresses B cell proliferation. Int. Immunol. 2008. 20: 671-681.
28. Clayton, E., Bardi, G., Bell, S. E., Chantry, D., Downes, C. P., Gray, A., Humphries, L. A. et al., A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 2002. 196: 753-763.
29. Donahue, A. C., Hess, K. L., Ng, K. L. and Fruman, D. A., Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. Int. Immunol. 2004. 16: 1789-1798.
30. Suzuki, H., Matsuda, S., Terauchi, Y., Fujiwara, M., Ohteki, T., Asano, T., Behrens, T. W. et al., PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 2003. 4: 280-286.
31. Anzelon, A. N., Wu, H. and Rickert, R. C., Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 2003. 4: 287-294.
32. Oak, J. S., Chen, J., Peralta, R. Q., Deane, J. A. and Fruman, D. A., The p85beta regulatory subunit of phosphoinositide 3-kinase has unique and redundant functions in B cells. Autoimmunity 2009. 42: 447-458.
33. Wen, L., Brill-Dashoff, J., Shinton, S. A., Asano, M., Hardy, R. R. and Hayakawa, K., Evidence of marginal-zone B cell-positive selection in spleen. Immunity 2005. 23: 297-308.
34. Donahue, A. C. and Fruman, D. A., PI3K signaling controls cell fate at many points in B lymphocyte development and activation. Semin. Cell Dev. Biol. 2004. 15: 183-197.
35. Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C. and Carsetti, R., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptorderived signals. J. Exp. Med. 1999. 190: 75-89.